Compare Ventas, Inc. (VTR) vs Omega Healthcare Investors, Inc. (OHI) Stock

Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 31.1x trailing P/E (24.3x forward), making it the more compelling value choice. Analysts rate Ventas, Inc. (VTR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Omega Healthcare Investors, Inc. (OHI) is the cheapest at 31.1x versus Ventas, Inc. at 159.6x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 24.3x.

Over the past 5 years, Ventas, Inc. (VTR) delivered a total return of +80.6%, compared to +63.0% for Omega Healthcare Investors, Inc. (OHI). A $10,000 investment in VTR five years ago would be worth approximately $18K today (assuming dividends reinvested). Over 10 years, the gap is even starker: OHI returned +132.8% versus VTR's +97.3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc. (OHI) is the lower-risk stock at 0.10β versus Ventas, Inc.'s 0.23β — meaning VTR is approximately 135% more volatile than OHI relative to the S&P 500. On balance sheet safety, Omega Healthcare Investors, Inc. (OHI) carries a lower debt/equity ratio of 102% versus 104% for Ventas, Inc. — giving it more financial flexibility in a downturn.

Omega Healthcare Investors, Inc. (OHI) is the more profitable company, earning 38.6% net margin versus 4.3% for Ventas, Inc. — meaning it keeps 38.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62.7% versus 14.2% for VTR. At the gross margin level — before operating expenses — OHI leads at 98.6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Omega Healthcare Investors, Inc. (OHI) trades at 24.3x forward P/E versus 114.3x for Ventas, Inc. — 90.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VTR: 2.9% to $88.70.

In this comparison, OHI (5.3% yield) pays a dividend. VTR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Omega Healthcare Investors, Inc. (OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.10), 5.3% yield, +132.8% 10Y return). Both have compounded well over 10 years (OHI: +132.8%, VTR: +97.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: VTR is a mid-cap quality compounder stock; OHI is a mid-cap income-oriented stock. OHI pays a dividend while VTR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.